{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:38:24Z","timestamp":1791412704091,"version":"4.3.3"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Cardiac sarcoidosis (CS) is an increasingly recognized cause of heart failure and arrhythmia. Historically challenging to identify, particularly in the absence of extracardiac sarcoidosis, diagnosis of CS has improved with advancements in cardiac imaging. Recognition as well as management may require interpretation of multiple imaging modalities. Echocardiography may serve as an initial screening study for cardiac involvement in patients with systemic sarcoidosis. Cardiac magnetic resonance imaging (CMR) provides information on diagnosis as well as risk stratification, particularly for ventricular arrhythmia in the setting of late gadolinium enhancement. More recently, <jats:sup>18<\/jats:sup>F-fluorodeoxyglucose position emission tomography (FDG-PET) has assumed a valuable role in the diagnosis and longitudinal management of patients with CS, allowing for the assessment of response to treatment. Hybrid FDG-PET\/CT may also be used in the evaluation of extracardiac inflammation, permitting the identification of biopsy sites for diagnostic confirmation. Herein we examine the approach to diagnosis and management of CS using multimodality imaging via a case-based review.<\/jats:p>","DOI":"10.3389\/fcvm.2021.785279","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T11:34:21Z","timestamp":1643283261000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Current State and Future Directions of Multimodality Imaging in Cardiac Sarcoidosis"],"prefix":"10.3389","volume":"8","author":[{"given":"Alison L.","family":"Wand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Chrispin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison G.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha A.","family":"Gilotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/ehjci\/jev142","article-title":"Advances in imaging for diagnosis and management of cardiac sarcoidosis","volume":"16","author":"Aggarwal","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of Sarcoidosis and Its Management","volume":"385","author":"Drent","year":"2021","journal-title":"Longo DL, ed N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac Sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.15420\/aer.2020.09","article-title":"Management of Cardiac Sarcoidosis in 2020","volume":"9","author":"Gilotra","year":"2020","journal-title":"Arrhythm Electrophysiol Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/j.jacc.2020.08.042","article-title":"Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review","volume":"76","author":"Trivieri","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ahj.2008.09.009","article-title":"Cardiac sarcoidosis","volume":"157","author":"Kim","year":"2009","journal-title":"Am Heart J."},{"key":"B8","first-page":"102","article-title":"Diagnostic standard and guidelines for sarcoidosis","volume":"27","author":"Hiraga","year":"2007","journal-title":"Jpn J Sarcoidosis Granulomatous Disord."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Hear Rhythm."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1093\/eurheartj\/ehw328","article-title":"Cardiac manifestations of sarcoidosis: Diagnosis and management","volume":"38","author":"Birnie","year":"2017","journal-title":"Eur Heart J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cardfail.2021.06.016","article-title":"Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review","author":"Gilotra","year":"2021","journal-title":"J Card Fail."},{"key":"B12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.17996\/anc.17-00042","article-title":"New Guidelines for Diagnosis of Cardiac Sarcoidosis in Japan","volume":"3","author":"Terasaki","year":"2017","journal-title":"Ann Nucl Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/0002-9149(89)90323-8","article-title":"Two-dimensional echocardiographic findings in systemic sarcoidosis","volume":"63","author":"Burstow","year":"1989","journal-title":"Am J Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1046\/j.1365-2796.2002.01058.x","article-title":"Determination of cardiac involvement in sarcoidosis by magnetic resonance imaging and Doppler echocardiography","volume":"252","author":"Skold","year":"2002","journal-title":"J Intern Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"CMC.S15713","DOI":"10.4137\/CMC.S15713","article-title":"Cardiac sarcoidosis: clinical manifestations, imaging characteristics, and therapeutic approach","author":"Houston","year":"2014","journal-title":"Clin Med Insights Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the american society of echocardiography and the european association of cardiovascular imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J Am Soc Echocardiogr."},{"key":"B17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/0002-8703(85)90524-1","article-title":"Echocardiographic evaluation of patients with systemic sarcoidosis","volume":"110","author":"Lewin","year":"1985","journal-title":"Am Heart J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0002-9149(98)00377-4","article-title":"Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy","volume":"82","author":"Yazaki","year":"1998","journal-title":"Am J Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: Diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta","year":"2008","journal-title":"Chest."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jacc.2016.12.012","article-title":"Test in Context: Myocardial Strain Measured by Speckle-Tracking Echocardiography","volume":"69","author":"Collier","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12947-019-0176-9","article-title":"Myocardial tissue characterisation using echocardiographic deformation imaging","volume":"17","author":"Moharram","year":"2019","journal-title":"Cardiovasc Ultrasound."},{"key":"B22","doi-asserted-by":"publisher","first-page":"897956","DOI":"10.1155\/2014\/897956","article-title":"Assessment of cardiac sarcoidosis with advanced imaging modalities","volume":"2014","author":"Orii","year":"2014","journal-title":"Biomed Res Int"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-019-01323-0","article-title":"Diagnostic and predictive value of speckle tracking echocardiography in cardiac sarcoidosis","volume":"20","author":"Di Stefano","year":"2020","journal-title":"BMC Cardiovasc Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ejhf.205","article-title":"Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis","volume":"17","author":"Joyce","year":"2015","journal-title":"Eur J Heart Fail."},{"key":"B25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/echo.14572","article-title":"Subclinical involvement of the heart and its associated factors in patients with sarcoidosis with normal systolic function using 2D speckle tracking","volume":"37","author":"Bayat","year":"2020","journal-title":"Echocardiography."},{"key":"B26","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/ehjci\/jez235","article-title":"Deterioration of biventricular strain is an early marker of cardiac involvement in confirmed sarcoidosis","volume":"21","author":"Kusunose","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ijcard.2016.10.073","article-title":"Early detection of cardiac involvement in sarcoidosis with 2-dimensional speckle-tracking echocardiography","volume":"227","author":"Schouver","year":"2017","journal-title":"Int J Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1111\/echo.14886","article-title":"Speckle tracking echocardiography can predict subclinical myocardial involvement in patients with sarcoidosis: A meta-analysis","volume":"37","author":"Barssoum","year":"2020","journal-title":"Echocardiography."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","article-title":"2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of Amer","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation."},{"key":"B30","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jaccao.2020.10.011","article-title":"Strain Imaging in Cardio-Oncology","volume":"2","author":"Liu","year":"2020","journal-title":"JACC CardioOncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1016\/j.ejca.2013.04.030","article-title":"Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: A systematic review and meta-analysis","volume":"49","author":"Kalam","year":"2013","journal-title":"Eur J Cancer."},{"key":"B32","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/ehjci\/jet159","article-title":"Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection","volume":"15","author":"Negishi","year":"2014","journal-title":"Eur Hear J Cardiovasc Imaging."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.jcmg.2017.08.005","article-title":"Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy","volume":"10","author":"Patel","year":"2017","journal-title":"JACC Cardiovasc Imaging."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","article-title":"Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis","volume":"45","author":"Smedema","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of Myocardial Damage in Patients With Sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation."},{"key":"B36","doi-asserted-by":"publisher","first-page":"496","DOI":"10.4330\/wjc.v8.i9.496","article-title":"Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathy","volume":"8","author":"Sano","year":"2016","journal-title":"World J Cardiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cardfail.2014.12.004","article-title":"Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: Application of cardiac magnetic resonance imaging and 18F-fluoro-2-deoxyglucose positron-emission tomography\/computerized tomography","volume":"21","author":"Tezuka","year":"2015","journal-title":"J Card Fail."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e007030","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2015.03.175","article-title":"Electrocardiographic abnormalities and risk of developing cardiac events in extracardiac sarcoidosis","volume":"189","author":"Nagao","year":"2015","journal-title":"Int J Cardiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","article-title":"Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis","volume":"10","author":"Kouranos","year":"2017","journal-title":"JACC Cardiovasc Imaging."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1016\/j.jacc.2009.11.011","article-title":"ACCF\/ACR\/AHA\/NASCI\/SCMR 2010 expert consensus document on cardiovascular magnetic resonance. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents","volume":"55","author":"Hundley","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3978\/j.issn.2223-3652.2015.12.13","article-title":"Cardiac sarcoidosis-state of the art review","volume":"6","author":"Hulten","year":"2016","journal-title":"Cardiovasc Diagn Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s10741-020-10035-z","article-title":"The role of cardiac magnetic resonance in diagnosis of cardiac sarcoidosis","volume":"26","author":"Tadic","year":"2021","journal-title":"Heart Fail Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1148\/radiol.2017162732","article-title":"T1 and T2 Mapping in recognition of early cardiac involvement in systemic sarcoidosis","volume":"285","author":"Puntmann","year":"2017","journal-title":"Radiology."},{"key":"B45","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1055\/a-0598-5099","article-title":"Diagnostic value of cardiac magnetic resonance strain analysis for detection of cardiac sarcoidosis","volume":"190","author":"Dabir","year":"2018","journal-title":"RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgeb Verfahren."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1111\/jce.14082","article-title":"Regional abnormalities on cardiac magnetic resonance imaging and arrhythmic events in patients with cardiac sarcoidosis","volume":"30","author":"Okada","year":"2019","journal-title":"J Cardiovasc Electrophysiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/ehjci\/jeu294","article-title":"Late gadolinium enhancement identified with cardiacmagnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death","volume":"16","author":"Nadel","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B48","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc Imaging."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e005001","DOI":"10.1161\/CIRCIMAGING.116.005001","article-title":"Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis","volume":"9","author":"Hulten","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"B50","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc Imaging."},{"key":"B51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.amjcard.2004.08.083","article-title":"Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis","volume":"95","author":"Chiu","year":"2005","journal-title":"Am J Cardiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac Sarcoidosis","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation."},{"key":"B53","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.amjcard.2020.08.007","article-title":"Utility of cardiac magnetic resonance imaging versus cardiac positron emission tomography for risk stratification for ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"134","author":"Gowani","year":"2020","journal-title":"Am J Cardiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1016\/j.hrthm.2017.10.036","article-title":"2017 AHA\/ACC\/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.jcmg.2019.12.011","article-title":"Right ventricular abnormalities on cardiovascular magnetic resonance imaging in patients with sarcoidosis","volume":"13","author":"Velangi","year":"2020","journal-title":"JACC Cardiovasc Imaging."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.119.014628","article-title":"Arrhythmogenic right ventricular cardiomyopathy: Characterization of left ventricular phenotype and differential diagnosis with dilated cardiomyopathy","volume":"9","author":"Cipriani","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B57","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1164\/rccm.201309-1668LE","article-title":"Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping","volume":"189","author":"Crouser","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"7457369","DOI":"10.1155\/2018\/7457369","article-title":"Cardiac magnetic resonance imaging for diagnosis of cardiac sarcoidosis: a meta-analysis","volume":"2018","author":"Zhang","year":"2018","journal-title":"Can Respir J"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1056\/NEJMoa1604267","article-title":"Safety of magnetic resonance imaging in patients with cardiac devices","volume":"377","author":"Nazarian","year":"2017","journal-title":"N Engl J Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1056\/NEJMoa1603265","article-title":"Assessing the risks associated with mri in patients with a pacemaker or defibrillator","volume":"376","author":"Russo","year":"2017","journal-title":"N Engl J Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s12350-017-1043-4","article-title":"A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American","volume":"25","author":"Slart","year":"2018","journal-title":"J Nucl Cardiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCULATIONAHA.110.952184","article-title":"Imaging of cardiac sarcoid lesions using fasting cardiac 18F-fluorodeoxyglucose positron emission tomography: An autopsy case","volume":"122","author":"Koiwa","year":"2010","journal-title":"Circulation."},{"key":"B64","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/BF00947964","article-title":"Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography","volume":"21","author":"Brudin","year":"1994","journal-title":"Eur J Nucl Med."},{"key":"B65","unstructured":"Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis16479\n            LewisPJ\n            SalamaA\n          J Nucl Med351994"},{"key":"B66","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J Nucl Cardiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET\/CT in carDiac sarcoid detection and therapy monitoring writing group","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"e000867","DOI":"10.1161\/CIRCIMAGING.113.000867","article-title":"Evaluation of known or suspected cardiac sarcoidosis","volume":"9","author":"Blankstein","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"B69","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3390\/jcm9030890","article-title":"In which patients with sarcoidosis is FDG PET\/CT Indicated?","volume":"9","author":"Keijsers","year":"2020","journal-title":"J Clin Med."},{"key":"B70","unstructured":"Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis198998\n            OkumuraW\n            IwasakiT\n            ToyamaT\n            IsoT\n            AraiM\n            OriuchiN\n          15585472J Nucl Med452004"},{"key":"B71","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijcard.2018.10.083","article-title":"Prevalence of 18F-fluorodeoxyglucose positron emission tomography abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"284","author":"Protonotarios","year":"2019","journal-title":"Int J Cardiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1016\/j.hrthm.2015.08.014","article-title":"Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: the potential role of occult inflammation in arrhythmogenesis","volume":"12","author":"Tung","year":"2015","journal-title":"Hear Rhythm."},{"key":"B73","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s12350-019-01746-4","article-title":"Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: the effect of a structured patient preparation protocol","volume":"28","author":"Christopoulos","year":"2021","journal-title":"J Nucl Cardiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1177\/0284185115600916","article-title":"Administration of unfractionated heparin with prolonged fasting could reduce physiological 18F-fluorodeoxyglucose uptake in the heart","volume":"57","author":"Masuda","year":"2016","journal-title":"Acta radiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/ph14121286","article-title":"Imaging in cardiac sarcoidosis: a narrative review with focus on novel PET tracers","volume":"14","author":"Saric","year":"2021","journal-title":"Pharmaceuticals."},{"key":"B76","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12410-017-9400-x","article-title":"Novel noninvasive nuclear medicine imaging techniques for cardiac inflammation","volume":"10","author":"Kircher","year":"2017","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"B77","doi-asserted-by":"publisher","first-page":"77807","DOI":"10.18632\/oncotarget.12799","article-title":"Somatostatin receptor based PET\/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI","volume":"7","author":"Lapa","year":"","journal-title":"Oncotarget"},{"key":"B78","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13550-016-0207-6","article-title":"A dual tracer 68Ga-DOTANOC PET\/CT and 18F-FDG PET\/CT pilot study for detection of cardiac sarcoidosis","volume":"6","author":"Gormsen","year":"2016","journal-title":"EJNMMI Res"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1093\/eurheartj\/ehv278","article-title":"Detection of cardiac sarcoidosis by macrophage-directed somatostatin receptor 2-based positron emission tomography\/computed tomography","volume":"36","author":"Reiter","year":"2015","journal-title":"Eur Heart J."},{"key":"B80","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12350-016-0495-2","article-title":"18F-fluoromisonidazole (FMISO) PET may have the potential to detect cardiac sarcoidosis","volume":"24","author":"Manabe","year":"2017","journal-title":"J Nucl Cardiol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/RLU.0000000000000653","article-title":"18F-FLT PET imaging in a patient with sarcoidosis with cardiac involvement","volume":"40","author":"Norikane","year":"2015","journal-title":"Clin Nucl Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.jcmg.2019.12.013","article-title":"Effect of Corticosteroid Dose and Duration on 18-Fluorodeoxyglucose Positron Emission Tomography in Cardiac Sarcoidosis","volume":"13","author":"Okada","year":"2020","journal-title":"JACC Cardiovasc Imaging."},{"key":"B83","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cardfail.2019.02.018","article-title":"Serial cardiac FDG-PET for the diagnosis and therapeutic guidance of patients with cardiac sarcoidosis","volume":"25","author":"Ning","year":"2019","journal-title":"J Card Fail."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.cardfail.2021.06.010","article-title":"Management of cardiac sarcoidosis using mycophenolate mofetil as a steroid-sparing agent","volume":"27","author":"Griffin","year":"2021","journal-title":"J Card Fail"},{"key":"B85","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cardfail.2020.08.013","article-title":"Clinical and imaging response to tumor necrosis factor alpha inhibitors in treatment of cardiac sarcoidosis: a multicenter experience","volume":"27","author":"Gilotra","year":"2021","journal-title":"J Card Fail."},{"key":"B86","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ahj.2019.10.003","article-title":"Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT)","volume":"220","author":"Birnie","year":"2020","journal-title":"Am Heart J."},{"key":"B87","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s12350-018-01504-y","article-title":"The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis","volume":"27","author":"Flores","year":"2020","journal-title":"J Nucl Cardiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1007\/s00259-018-4001-8","article-title":"Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET\/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia","volume":"45","author":"Muser","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B91","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ijcard.2017.03.033","article-title":"Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging","volume":"241","author":"Bravo","year":"2017","journal-title":"Int J Cardiol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10554-020-02090-2","article-title":"Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study","volume":"37","author":"Kebed","year":"2021","journal-title":"Int J Cardiovasc Imaging."},{"key":"B93","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/ehjci\/jex340","article-title":"Diagnostic accuracy and prognostic value of simultaneous hybrid 18 F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis","volume":"19","author":"Wicks","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B94","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","article-title":"Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis","volume":"11","author":"Dweck","year":"2018","journal-title":"JACC Cardiovasc Imaging."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1007\/s12350-018-01578-8","article-title":"Same day comparison of PET\/CT and PET\/MR in patients with cardiac sarcoidosis","volume":"27","author":"Wisenberg","year":"2020","journal-title":"J Nucl Cardiol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.785279\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T11:34:26Z","timestamp":1643283266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.785279\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":95,"alternative-id":["10.3389\/fcvm.2021.785279"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.785279","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"article-number":"785279"}}